ATC Group: A06AD17 Sodium phosphate

The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.

Position of A06AD17 in the ATC hierarchy

Level
Code
Title
1
Alimentary tract and metabolism
2
Laxatives
3
Laxatives
4
Osmotically acting laxatives
5
A06AD17
Sodium phosphate

Defined daily dose

The DDD is the assumed average maintenance dose per day for a drug used for its main indication in adults. The DDD is a unit of measurement and does not necessarily reflect the recommended or Prescribed Daily Dose. Therapeutic doses for individual patients and patient groups will often differ from the DDD as they will be based on individual characteristics (such as age, weight, ethnic differences, type and severity of disease) and pharmacokinetic considerations.

Route
Amount
ORAL - Oral
50 g

Active ingredients in A06AD17

Active Ingredient
Description

Medicines in this ATC group

Drug
Countries

Poland United Kingdom

Ireland South Africa

Ecuador

Ecuador Spain

Singapore

Related product monographs

Title
Type
Country
Summary of Product Characteristics (SPC)
IE